Condition

Non-segmental Vitiligo clinical trials and research

• 8Clinical trials
• 15Countries

Newest Non-segmental Vitiligo clinical trials

All recruiting trials (8)

• Test of ACT-777991 in adults with non-segmental vitiligo

  This study tests whether ACT-777991 can help restore skin color in adults with non-segmental vitiligo, compared to placebo.

  Recruiting Phase 2 Idorsia Pharmaceuticals Ltd. · Los Angeles, California and 4 other locations · NCT07667569

• Different doses of GIA632 for adults with non-segmental vitiligo

  This trial tests whether different doses of GIA632 can safely help restore skin pigment in adults with non-segmental vitiligo.

  Recruiting at 85 sites Phase 2 Novartis · Birmingham, Alabama and 84 other locations · NCT07431177

• SHR0302 tablets with or without SHR0302 base gel for non-segmental vitiligo

  This trial will test whether SHR0302 tablets, alone or together with an SHR0302 base gel, help adults with non-segmental vitiligo and are safe to use.

  Recruiting Phase 2 Jiangsu HengRui Medicine Co., Ltd. · Jinan, Shandong · NCT07251595

• Phase 2 EI-001 for non-segmental vitiligo

  This trial will test whether the antibody drug EI-001 can help adults (18–65) with non‑segmental vitiligo regain skin pigment more than a placebo.

  Recruiting at 7 sites Phase 2 Elixiron Immunotherapeutics (Hong Kong) Ltd. · Huntington Beach, California and 7 other locations · NCT07223229

• VC005 tablets for people with non-segmental vitiligo

  This trial will test VC005 tablets to see if they safely help adults aged 18–70 with non-segmental vitiligo regain skin pigment.

  Recruiting Phase 2 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijng · NCT07172347

• Roflumilast 0.3% foam for children with non-segmental vitiligo

  This trial will try a roflumilast 0.3% topical foam to see if it helps children and teens (ages 2–17) with non-segmental vitiligo affecting small areas including the face.

  Recruiting Phase 2 Derm Texas, PLLC · Dallas, Texas · NCT07105254

• ICP-332 treatment for non-segmental vitiligo

  This trial will test whether oral ICP-332 tablets help people with non-segmental vitiligo (including adolescents in the Phase III part) who have at least 5% body surface area affected and facial involvement regain skin pigment better than placebo.

  Recruiting at 4 sites Phase 2/3 Beijing InnoCare Pharma Tech Co., Ltd. · Wuhu, Anhui and 44 other locations · NCT07047612

• Comparing needling and microneedling treatments for vitiligo

  This study is testing whether needling or microneedling treatments, followed by light therapy, can help people with stable vitiligo see better skin color improvement.

  Recruiting Phase 4 Khyber Teaching Hospital · Peshawar, Khyber Pakhtunkhwa · NCT06991972

Related topics

Quick answers

How many Non-segmental Vitiligo clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in China (4 trials), United States (4 trials), Taiwan (1 trial), Pakistan (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 2/3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →